Syngen Biotech Co.,Ltd. (SYNGEN BIOTECH CO LTD) aksje

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredients under the Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL brands; and private labelling services. It also provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company serves the sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. The company was founded in 1988 and is based in Tainan City, Taiwan.